(Q37052408)

17 August 2017

Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report (English)

1 reference

obsessive-compulsive disorder

17 August 2017

0 references

Michele Fornaro

1

0 references

author name string

Filippo Gabrielli

2

1 reference

17 August 2017

Chiara Mattei

3

1 reference

17 August 2017

Valentina Vinciguerra

4

1 reference

17 August 2017

Pantaleo Fornaro

5

1 reference

17 August 2017

23 December 2008

1 reference

Annals of General Psychiatry

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

26

1 reference

Creative Commons Attribution 2.0 Generic

17 August 2017

start time

1 December 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1744-859x-7-26

0 references

cites work

Aripiprazole acts as a selective dopamine D2 receptor partial agonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

Disability and family burden in obsessive-compulsive disorder

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

Clinical implications of insight assessment in obsessive-compulsive disorder

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

Clinical characteristics and treatment response in poor and good insight obsessive-compulsive disorder

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

Benefits of switching from typical to atypical antipsychotic medications: a longitudinal study in a community-based setting.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

The Brown Assessment of Beliefs Scale: reliability and validity.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621216

4 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/19105842

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1744-859X-7-26

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

1 reference